GSK Launches US Inhaler Recycling Scheme
UK-headquartered medical products manufacturer GlaxoSmithKline (GSK) has introduced a new programme in the USA to help consumers recycle their empty respiratory inhalers and keep waste out of landfills. The programme, Complete the Cycle, is being offered to community-based retail pharmacies across the USA to make available to their customers. Currently, inhalers may not be recycled by curb-side recyclers, and therefore likely go to landfills.
Pharmacy enrollment in the program is ongoing and consumers can view a regularly updated list of participating pharmacies on www.GSKCompleteTheCycle.com.
“The Complete the Cycle recycling program provides an in-store location for people to drop off empty GSK respiratory inhalers for shipment to a specialised recycler,” said Jorge Bartolome, senior vice president of GSK’s respiratory business area. “GSK piloted the programme earlier in five markets and collected nearly 2,700 inhalers. By expanding to 31 US markets, we hope to recycle more than 100,000 empty GSK inhalers.”
Programme Details
Participating pharmacies will have a Complete the Cycle collection container where customers can deposit empty inhalers as they pick up new prescriptions. Once the boxes are full, pharmacies send the inhalers directly to a specialised recycler where the inhalers will be recycled. The plastics will be used to make new household products, such as plastic hangers and plastic flower pots. The recovered aerosol canister will be sent to a specialist company that will capture remaining gas and recycle the metal components.The inhalers will not be recycled to produce new inhalers.
The Complete the Cycle programme is being administered for GSK by TerraCycle, the world’s leader in the collection and reuse of non-recyclable post-consumer waste. TerraCycle is managing the recruitment of pharmacies and the roll-out of programme materials to the participating stores.
GSK Environmental Sustainability
The Complete the Cycle recycling programme is designed to reduce the environmental impact of GSK inhalers sent to landfills. It is one of several efforts GSK has in place that focus on environmental sustainability. GSK’s broader sustainability initiatives can be found in the company’s 2011 Corporate Responsibility Report.
The GSK programme aligns with other efforts offered by many pharmacies to collect and recycle items, such as empty drink containers, plastic bags or pill bottles, and was designed in response to the growing US interest in environmental sustainability. Studies have shown that recycling and sustainability are increasingly important to American consumers. As an example, a 2011 study from SC Johnson and GfK Roper showed increasing interest in recycling, with 58% of American respondents reporting that they recycle on a regular basis.
GSK is committed to providing medicines that make a difference while protecting natural resources. The company aims to minimise environmental impact across the value chain and lifecycle of its products by setting ambitious goals to reduce its carbon footprint, water footprint and waste. Among the long-term goals, GSK aims to be carbon neutral by 2050, with this ambition extending across the company’s operations, suppliers and customers.
Another US recycling scheme in operation is BD's ecofinity programme which recycles medical sharps. For more information about this see Medical Plastics News July-August 2012. Image Caption: Complete the Cycle was also trialled in the UK in 2011. Image courtesy of MRW Magazine.